SCHEMBL22893773

SCHEMBL22893773

c1ccc(-c2nc(-c3ccc4oc5ccc6ccccc6c5c4c3)nc(-n3c4ccccc4c4cc(-c5ccc6c(c5)c5ccccc5n6-c5ccccc5)ccc43)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
SIRT2 Q8IXJ6 1/20 0.38
SIRT1 Q96EB6 1/20 0.38
ATM Q13315 1/20 0.38
ABCG2 Q9UNQ0 4/20 0.36
PAX8 Q06710 2/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1A2 P05177 1/20 0.36
FYN P06241 1/20 0.36
MAPK3 P27361 1/20 0.36
AHR P35869 1/20 0.36
PTGER4 P35408 1/20 0.35
PTGES O14684 1/20 0.35
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
TSHR P16473 2/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22894171 0.97 SIRT2 (0.36) KDM4EL3MBTL1SIRT2SIRT1ATM
SCHEMBL22894072 0.94 L3MBTL1 (0.36) KDM4EL3MBTL1SIRT2SIRT1ATM
SCHEMBL22893730 0.94 SIRT2 (0.38) KDM4EL3MBTL1SIRT2SIRT1ATM
SCHEMBL22894172 0.94 ABCG2 (0.36) KDM4EL3MBTL1SIRT2SIRT1ATM
SCHEMBL24152069 0.92 ABCG2 (0.41) KDM4EL3MBTL1SIRT2SIRT1ABCG2
SCHEMBL22893782 0.92 SIRT2 (0.34) KDM4EL3MBTL1SIRT2SIRT1ATM
SCHEMBL17246664 0.91 L3MBTL1 (0.43) KDM4EL3MBTL1SIRT2SIRT1ATM
SCHEMBL22893795 0.91 KDM4E (0.34) KDM4EL3MBTL1SIRT2SIRT1ATM
SCHEMBL23981379 0.90 L3MBTL1 (0.46) KDM4EL3MBTL1SIRT2SIRT1ATM
SCHEMBL20821788 0.90 SIRT2 (0.35) KDM4EL3MBTL1SIRT2SIRT1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210013411-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2021-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210013411-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 KDM4E 2673/4885L3MBTL1 1367/4885SIRT2 1235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.